QUESTS - QUantum Enhanced Scanning Technology for community healthcare Settings

磁共振成像(MRI)和计算机断层扫描(CT)等医疗扫描仪对现代医疗保健至关重要。尽管具有灵活性，但医疗扫描仪的使用受到限制，因为它们的尺寸、资本成本和运行成本，所有这些都限制了它们在医院的使用。因此，英国每百万人拥有6.1台核磁共振扫描仪(约500台，提供380万次扫描[1\])。**曲**量子**E**增强**S**社区医疗保健技术**S**etings(**Quest**)是一款小型多传感器医疗扫描仪，适用于传统核磁共振和CT设备不太适合的环境。目标环境可能是全科医生诊所、社区诊所、药剂师、救护车和流动军事医院。该项目旨在通过分散扫描能力来增强基于社区的医疗保健。这提供了提高诊断和治疗速度的机会，从而改善了患者的结果，同时降低了扫描的总体成本。Quest计划将通过桌面研究(阶段1)和原型(阶段2)来解决技术挑战。阶段1报告将包含：1.临床和NHS需求的定义2.3.制度理念。技术可行性研究，包括文献综述。知识产权的美化和捕获5.监管和测试途径概述6.精益制造研究7。上市路线和商业计划8.风险登记与缓解阶段2将输出：1。详细设计小规模子系统演示2。制造和测试子系统演示器3。小规模示范成果报告4。修改了全系统原型的分系统设计和详细设计。搭建了全系统样机并进行了演示。审查并报告结果7.从第一阶段开始更新风险、知识产权、商业和制造计划1 Quest计划由Metlase(UniPart的子公司)牵头，分包的支持来自以下机构：苏塞克斯大学、谢菲尔德哈勒姆大学、谢菲尔德儿童医院、Medilink和UniPart物流

Medical scanners such as Magnetic Resonance Imaging (MRI) and Computerised Tomography (CT) are critical to modern healthcare. Despite their flexibility, the use of medical scanners is restricted because of their: size, capital cost, and running costs, all of which limits their use to hospitals. Consequently, the UK has 6.1 MRI scanners per million people (approx 500, delivering 3.8 million scans\[1\]).**QU**antum **E**nhanced **S**canning **T**echnology for community healthcare **S**ettings (**QUESTS**) is a small form-factor multi-sensorial medical scanner, for environments where traditional MRI and CT equipment is poorly suited. Targeted environments could be; GPs surgeries, community clinics, pharmacists , ambulances and mobile military hospitals. The project aims to empower community-based healthcare with decentralising scanning capability. This offers the opportunity to both increase the clock-speed of diagnosis and speed of treatment, leading to improved patient outcomes, while lowering the overall cost of scanning.The QUESTS programme will address the technical challenges with a desktop study (phase1) and prototype (phase2). The phase1 report will contain:1. Definition of clinical and NHS need2. System concept3. Technical feasibility study, including a literature review4. IP landscaping and capture5. Overview of regulatory and testing pathways6. Lean manufacturing study7. Route-to-market and commercial plan8. Risk register with mitigationsPhase2 will output:1. Detailed design of small-scale sub-system demonstrators2. Manufacture and test subsystem demonstrators3. Report of small-scale demonstrator results4. Revised sub-system design and detailed design of full-system prototype5. Built full-system prototype and demonstrate6. Review and report results7. Updated risk, IP, commercial and manufacturing plans from phase1The QUESTS programme is being lead by MetLase (a Unipart subsidiary) with sub-contracted support from: The university of Sussex, Sheffield Hallam University, Sheffield Children's Hospital, Medilink, and Unipart Logistics